SNPS vs COHU

For growth investors, Synopsys, Inc.

(SNPS) is the stronger pick with 15. 1% revenue growth year-over-year, versus 12. 7% for Cohu, Inc. (COHU). Synopsys, Inc. (SNPS) offers the better valuation at 62. 7x trailing P/E (34. 9x forward), making it the more compelling value choice. Analysts rate Synopsys, Inc. (SNPS) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Synopsys, Inc.

is actually cheaper at 34. 9x.

Over the past 5 years, Synopsys, Inc.

(SNPS) delivered a total return of +112. 4%, compared to +31. 4% for Cohu, Inc. (COHU). Over 10 years, the gap is even starker: SNPS returned +953. 8% versus COHU's +345. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Synopsys, Inc.

(SNPS) is the lower-risk stock at 1. 79β versus Cohu, Inc. 's 2. 13β — meaning COHU is approximately 19% more volatile than SNPS relative to the S&P 500. On balance sheet safety, Cohu, Inc. (COHU) carries a lower debt/equity ratio of 46% versus 50% for Synopsys, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Synopsys, Inc.

(SNPS) is pulling ahead at 15. 1% versus 12. 7% for Cohu, Inc. (COHU). On earnings-per-share growth, the picture is similar: Cohu, Inc. grew EPS -6. 7% year-over-year, compared to -44. 6% for Synopsys, Inc.. Over a 3-year CAGR, SNPS leads at 15. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Synopsys, Inc.

(SNPS) is the more profitable company, earning 18. 9% net margin versus -16. 4% for Cohu, Inc. — meaning it keeps 18. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SNPS leads at 13. 0% versus -13. 3% for COHU. At the gross margin level — before operating expenses — SNPS leads at 77. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Synopsys, Inc.

(SNPS) trades at 34. 9x forward P/E versus 93. 2x for Cohu, Inc. — 58. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SNPS: 7. 8% to $543. 57.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Synopsys, Inc.

(SNPS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+953. 8% 10Y return). Cohu, Inc. (COHU) carries a higher beta of 2. 13 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SNPS: +953. 8%, COHU: +345. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SNPS is a mid-cap high-growth stock; COHU is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.